Studies of tai chi in people
156 studies gave tai chi to people and measured what changed
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases WOMAC pain-3.22 points (95% CI -3.96 to -2.48); P < 0.001 up: Improves physical function | Randomized trial12 weeks | 116 peopleolder adultsOlder adults; knee osteoarthritis | Journal of pain research, Nov 6, 2026 |
| Trial | 58 peoplePatients with cerebral small vessel disease and mild cognitive impairment | Frontiers in cell and developmental biology, Oct 30, 2026 | |
up: Improves fatigue up: Improves sleep qualitymedian: 6.0, IQR: 5.0–7.0 up: Improves 6-min walk distancemean: 490.2, SD: 50.7 | Randomized trial12 weeks | 64 people31 (48.4%) were male18-60 yearsKidney transplant recipients aged 18–60 years who were at least 1 month post-transplantation | Nursing research and practice, Oct 13, 2026 |
up: Improves cognitive functionβ = 4.95, 95% CI [3.98, 5.92] up: Increases cerebral blood flowβ = 15.29, 95% CI [12.58, 17.99] up: Increases nitric oxideβ = 10.41, 95% CI [5.02, 15.79] | Randomized trial12 weeks | 40 peoplepostmenopausal womenaged 50–75 yearsPostmenopausal women with MCI | Frontiers in aging neuroscience, Sep 25, 2026 |
down: Decreases timed Up and Go time−2.52 s (95% CI, −3.43 to −1.61) down: Decreases knee pain−3.22 points (95% CI, −5.29 to −1.16) | Randomized trial12 weeks | 96 peopleaged 65–85 yearsCommunity-dwelling adults with sarcopenic knee osteoarthritis | Osteoarthritis and cartilage open, Sep 23, 2026 |
up: Increases skeletal muscle mass down: Decreases percentage of fat mass up: Improves sit-stand test | Trialsix months | 123 people60 to 74 yearsOlder adults aged 60 to 74 years without severe cognitive impairment or risk of sarcopenia | Sports (Basel, Switzerland), Sep 1, 2026 |
down: Decreases 12-HETE down: Decreases 1-arachidonoylglycerol up: Increases 18-HEPE | Trialfour sessions on non-consecutive days within a 10 d window | 16 peoplewomen58.9 ± 5.2 years oldSelf-reported postmenopausal women | Frontiers in medicine, Aug 31, 2026 |
| Randomized trial12 weeks | 50 peopleolder adultsOlder adults; Parkinson disease | Archives of physical medicine and rehabilitation, Aug 28, 2026 | |
down: Decreases body fat percentage down: Decreases fasting blood glucose down: Decreases IFN-γ | Trial12 weeks | 19 peoplemiddle-aged and elderlyMidlife adults; Older adults; in people with pre-diabetes, after 12 weeks | Current Drug Therapy, Jul 16, 2026 |
| Review of trialsranged between 1 week and 240 weeks | 221,279 people pooledmost reviews (n = 135) included both female and male participants (females only, n = 22)ranged between 20 and 79 yearsAdults aged 18 years and older (healthy and clinical) | Pain reports, Jul 6, 2026 | |
down: Decreases stressfrom 15.96 ± 5.71 to 12.46 ± 3.47 (t = 4.274; p < 0.000) | Trial21 days | 28 peopleolder adultsOlder adults | Nurse and Health Jurnal Keperawatan, Jul 6, 2026 |
| Review of trials | 2,095 people pooledmiddle-aged and older adults (mean age 58 to 79 years)Midlife adults; Older adults; Patient cohorts | Frontiers in medicine, Jul 2, 2026 | |
down: Decreases loneliness up: Improves social self-efficacy | Randomized trialsix months | 140 people52% women and 48% menrange 65 to 85 years, mean 70.03 ± 8.46 yearsOlder adults living alone | BMC psychology, Jul 2, 2026 |
up: Improves static balance+94.0%, Cohen's d=1.85, p<0.001 up: Improves dynamic balance-17.8% TUG time, p<0.001 up: Improves Berg Balance Scale+7.0%, p<0.001 | Trial12 weeks | 40 people65-75 yearsOlder adults | Interdisciplinary Academic and Research Journal, Jul 2, 2026 |
up: Improves postural stability up: Improves gait quality | Randomized trial12 weeks | 68 peopleBothmean 71.1 yearsOlder adults | Journal of neuroengineering and rehabilitation, Jun 24, 2026 |
up: Increases physical activityfrom 14.2 MET h/wk at baseline to 28.7 MET h/wk post-intervention (p < 0.001) up: Improves social participationp = 0.014 | Trial8 weeks | 60 people60-77 yearsOlder adults; adults aging with mobility disabilities | Healthcare (Basel, Switzerland), Jun 18, 2026 |
down: Decreases plantar tactile sensation thresholdp = 0.007, OR = 0.111, 95%CI: 0.023-0.544 down: Decreases ankle proprioception thresholdp < 0.002, η 2 p = 0.355 | Randomized trial8 weeks | 38 peopleBoth71.5 ± 5.3 yearsOlder adults; peripheral neuropathy | Frontiers in sports and active living, Jun 17, 2026 |
up: Improves balance | Randomized trial12 weeks | 60 people60–80 yearsOlder adults; Patient cohorts | Journal of Health Wellness and Community Research, Jun 2, 2026 |
up: Improves muscle strengthp = 0.003 | Trial | 10 peopleOlder adults | Jurnal Keperawatan Profesional (KEPO), May 31, 2026 |
up: Improves Mini-Mental State ExaminationΔ = 3.29, 0.81 to 5.77, pHolm = 0.0492 up: Improves immediate story recallΔ = 9.84, 3.22 to 16.46, pHolm = 0.0234 | Randomized trial24 weeks | 76 peopleBoth86.8 ± 4.1 yearsThe oldest old; assisted living facility residents aged ≥80 | Journal of affective disorders, May 5, 2026 |
up: Improves quality of life | Randomized trial14 weeks | Parkinson's disease (Hoehn and Yahr stages 2-3) | Behavioural brain research, May 2, 2026 |
down: Decreases low-density lipoprotein cholesterol up: Improves short Physical Performance Battery up: Improves WHOQOL quality of life | Randomized trial12 weeks | 113 peoplemiddle-aged and older adults, mean 62.3 yearsMidlife adults; Older adults | JMIR aging, Apr 23, 2026 |
down: Decreases COP-RMSml up: Improves Timed Up-and-Go | Randomized trial8 weeks | 40 peopleolder adultsOlder adults; older adults with diabetic peripheral neuropathy | Brain research, Apr 17, 2026 |
down: Decreases Pittsburgh Sleep Quality IndexP < 0.001 up: Increases N3 sleep stage proportion+23.1% up: Increases delta wave powerP < 0.01 | Randomized trial12 weeks | 67 people65-75 yearsOlder adults; mild sleep disturbance | Frontiers in physiology, Apr 15, 2026 |
| Randomized trial12-week | 69 peopleolder adultsOlder adults; postintervention, within Tai Chi group | Journal of applied biomechanics, Mar 31, 2026 | |
up: Improves cognitive function up: Improves gait up: Increases hip range of motion | Trialthree months | 40 peopleBothaged 60 years and olderParticipants aged 60 years and older with mild cognitive impairment | Frontiers in physiology, Mar 23, 2026 |
down: Decreases 4-meter walk test time down: Decreases sit-to-stand test time up: Increases handgrip strength | Trialsix months | 81 peopleolder womenaged 60 to 74 yearsCommunity-dwelling older Mexican women aged 60 to 74 | Healthcare (Basel, Switzerland), Mar 5, 2026 |
down: Decreases knee pain up: Improves joint range of motion up: Improves muscle strength | Trial20–30 minutes | older adultsOlder adults; osteoarthritis | Jurnal Kesehatan Amanah, Feb 24, 2026 |
down: Decreases fasting blood glucose down: Decreases body weight up: Increases gut microbiota diversity | Trial6 months | 36 peopleIn patients with type 2 diabetes mellitus | Frontiers in public health, Feb 6, 2026 |
up: Improves Cumberland Ankle Instability Tool+10.32 vs +2.84 points, P<.01 down: Decreases pain intensityP<.05 up: Improves balanceP<.05 | Randomized trial12 weeks | 50 peopleBoth65.44±8.75yOlder adults; functional ankle instability | Archives of rehabilitation research and clinical translation, Feb 4, 2026 |
up: Improves positive emotional changesBTJQ > GBTJQ > GTJQ > TJQ | Randomized trialacute | MenelderlyOlder adults | Frontiers in psychology, Feb 4, 2026 |
down: Decreases systolic blood pressure down: Decreases IL-6 up: Increases IL-10 | Randomized trial24 weeks | 31 peoplePatients with hypertension and coronary heart disease | BMC complementary medicine and therapies, Feb 3, 2026 |
down: Decreases depression up: Improves balance ability | Randomized trial12 and 24 weeks | 46 peoplemean age 61 yearsOlder adults; advanced cancer | European journal of oncology nursing : the official journal of European Oncology Nursing Society, Jan 30, 2026 |
up: Improves global cognitionΔ = +0.46, p = 0.0045 up: Increases skeletal muscle mass down: Decreases IL-6 | Randomized trial12 weeks | 22 peopleBothmean 62.3 yearsOlder adults; 12-form Chen-style Tai Chi arm, 12 weeks, versus control | Experimental gerontology, Jan 22, 2026 |
up: Improves cognitive function down: Decreases homocysteine | Randomized trial24-week | 26 peopleIn patients with CSVD | GeroScience, Jan 21, 2026 |
up: Improves working memory0-back accuracy +0.118, 95% CI: 0.048-0.188 up: Improves global cognitionMoCA +3.07, 95% CI: 0.89-5.25 | Randomized trial26 weeks | 93 peopleolder adultsOlder adults; mild cognitive impairment | Frontiers in public health, Jan 6, 2026 |
down: Decreases painVAS SUCRA 0.97 up: Improves physical healthSF-36 PCS SUCRA 0.89 | Review of trials | 1,457 people pooledmiddle-aged and older adultsMidlife adults; Older adults; SUCRA ranking in Bayesian network meta-analysis | Frontiers in public health, Jan 6, 2026 |
up: Increases physical activity up: Improves social connectedness down: Decreases loneliness | Trial8 weeks | 60 peopleolder adultsOlder adults; aging with mobility disabilities | GSA 2025 abstract, Dec 31, 2025 |
up: Increases deep stabilizing muscle activation1.327 ± 0.085 vs 1.468 ± 0.246 down: Decreases lumbar rotation around the z-axis−2.096 ± 1.025 vs −1.957 ± 0.682 | Trial | 12 people6 males, 6 femalesHealthy adults | Frontiers in sports and active living, Dec 5, 2025 |
down: Decreases insomnia severitybetween group difference of 0.68 (−∞ to 2.00) | Randomized trialthree month programme | 200 people≥50 yearsMiddle aged and older adults aged ≥50 years who were ethnic Chinese and had a diagnosis of chronic insomnia | BMJ (Clinical research ed.), Nov 26, 2025 |